# Phase 1 brain cancer trials recruiting: 53 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 53 trials in phase 1 for brain cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 1 brain cancer trials: 53 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-1/brain-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 53
- Recruiting or not yet: 53
- Read on: November 19, 2026

## Trials

The 25 newest of 53, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 10, 2026 | NCT07929909 | A Phase I Clinical Study of YN003 in the Treatment of Glioma | Beijing Inno Medicine Co., Ltd. | Phase 1 | Recruiting | Glioma, Glioblastoma, Brain Neoplasms | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07929909) |
| September 18, 2026 | NCT07826949 | A Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma. | Sponsor not shown (see the record) | Phase 1 | Not yet recruiting | Recurrent High-Grade Gliomas, Brain Neoplasm, Glioma | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07826949) |
| August 19, 2026 | NCT07773454 | Study of Zanzalintinib in Children and Adolescents With Relapsed or Refractory Solid Tumors | Exelixis | Phase 1 | Not yet recruiting | Cancer, Pediatric Cancer | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07773454) |
| July 31, 2026 | NCT07739017 | OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed Glioblastoma | Olivia Newton-John Cancer Research Institute | Phase 1 | Not yet recruiting | Recurrent Glioblastoma, Newly Diagnosed MGMT Unmethylated Glioblastoma | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07739017) |
| July 29, 2026 | NCT07733674 | Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma... | Radiomedix, Inc. | Phase 1 | Recruiting | Glioblastoma Multiforme (GBM), Pancreatic Ductal Adenocarcinoma (PDAC) | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07733674) |
| June 24, 2026 | NCT07664176 | NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors | Children's National Research Institute | Phase 1 | Recruiting | Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma, High Grade Gliomas, Medulloblastoma Recurrent, Ependymoma... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07664176) |
| June 18, 2026 | NCT07655583 | OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic Therapy | M.D. Anderson Cancer Center | Phase 1 | Recruiting | Brain Metastasis, Stereotactic Radiosurgery, Resection, Systemic Therapy | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07655583) |
| June 2, 2026 | NCT07619599 | A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer... | City of Hope Medical Center | Phase 1 | Recruiting | Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Brain, Oligoprogressive Lung Non-Small... | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07619599) |
| May 6, 2026 | NCT07569263 | IL-8 Receptor Modified Patient-Derived Activated CD70 CAR T Cell Therapy in Adults With Brain Metastases | University of Florida | Phase 1 | Recruiting | Brain Metastases | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07569263) |
| March 27, 2026 | NCT07496073 | A Phase I, Single-arm, Open-label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of CHT101 Cell Infusion... | Tianjin Medical University Cancer Institute and Hospital | Phase 1 | Not yet recruiting | Brain (Nervous System) Cancers | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07496073) |
| March 6, 2026 | NCT07454668 | Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases | Baptist Health South Florida | Phase 1 | Not yet recruiting | Breast Cancer, HER2-positive Breast Cancer, Brain Metastases, Cancer, Cancer Metastatic | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07454668) |
| February 5, 2026 | NCT07390539 | B7-H3.CD28Z.CART in CNS Neoplasms | Sponsor not shown (see the record) | Phase 1 | Recruiting | Central Nervous System Neoplasms, Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Pediatric, Brain Tumor Adult... | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07390539) |
| January 9, 2026 | NCT07331064 | Gallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Glioma and Atypical Teratoid... | Sponsor not shown (see the record) | Phase 1 | Not yet recruiting | High Grade Gliomas, Atypical Teratoid Rhabdoid Tumors (ATRT), Diffuse Midline Glioma, DIPG, Diffuse Intrinsic Pontine... | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07331064) |
| November 28, 2025 | NCT07254845 | A PROSPECTIVE, SINGLE-CENTERED, ASSESSOR-BLINDED STUDY TO EVALUATE THE CLINICAL EFFICACY OF THE PROPOSED CELL/TISSUE HISTOPATHOLOGY... | VPIX Medical | Phase 1 | Not yet recruiting | Frozen Sections, Indocyanine Green (ICG), Brain Tumor | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07254845) |
| September 17, 2025 | NCT07179328 | Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy | Sunnybrook Health Sciences Centre | Phase 1 | Recruiting | GBM, Glioblastoma Multiforme (GBM), Glioblastoma Multiforme of Brain, Glioblastoma Multiforme Glioma, HGG, Glioma... | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07179328) |
| August 24, 2025 | NCT07139990 | Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM) | University of Texas Southwestern Medical Center | Phase 1 | Recruiting | Small Cell Lung Cancer Extensive Stage, Brain Metastases, Solid Tumor, Adult, Thoracic Cancer, Sarcoma,Soft Tissue... | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07139990) |
| August 21, 2025 | NCT07134842 | A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment. | University College, London | Phase 1 | Recruiting | Glioblastoma, Gliosarcoma, Adult, Glioblastoma - Category | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07134842) |
| July 25, 2025 | NCT07087002 | GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults | Stanford University | Phase 1 | Recruiting | Medulloblastoma, Central Nervous System Embryonal Tumor, Refractory Medulloblastoma, Recurrent Medulloblastoma... | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07087002) |
| July 14, 2025 | NCT07063693 | ABY-029 Glioma Trial | Dartmouth-Hitchcock Medical Center | Phase 1 | Recruiting | Intracranial Tumor | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07063693) |
| April 27, 2025 | NCT06946680 | IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly... | University of Florida | Phase 1 | Not yet recruiting | High-grade Glioma, Diffuse Intrinsic Pontine Glioma | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06946680) |
| April 6, 2025 | NCT06914479 | Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult... | University of Michigan Rogel Cancer Center | Phase 1 | Recruiting | Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant, Recurrent Malignant Brain Neoplasm, Resectable Brain Neoplasm | 11 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06914479) |
| March 10, 2025 | NCT06867978 | Multi-center Study on CCeLL-In Vivo's Clinical Efficacy for Intraoperative Brain Tumor Diagnosis. | VPIX Medical | Phase 1 | Not yet recruiting | Frozen Sections, Indocyanine Green, Brain Tumor | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06867978) |
| February 7, 2025 | NCT06815432 | GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma | Baylor College of Medicine | Phase 1 | Recruiting | Glioblastoma Multiforme of Brain | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06815432) |
| February 4, 2025 | NCT06807619 | A Study of Sotorasib in People With Brain Tumors | Memorial Sloan Kettering Cancer Center | Phase 1 | Recruiting | Brain Tumor | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06807619) |
| December 19, 2024 | NCT06742593 | Study of MT027 in Patients with Brain, Meninges, and Spinal Cord Metastatic Solid Tumors | Suzhou Maximum Bio-tech Co., Ltd. | Phase 1 | Not yet recruiting | Brain (Nervous System) Cancers, Brain and Central Nervous System Tumors, Brain Tumors | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06742593) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Florida | 4 |
| Baptist Health South Florida | 3 |
| M.D. Anderson Cancer Center | 3 |
| VPIX Medical | 2 |
| City of Hope Medical Center | 2 |
| Baylor College of Medicine | 2 |
| Sunnybrook Health Sciences Centre | 2 |
| University of Michigan Rogel Cancer Center | 1 |
| A2A Pharmaceuticals Inc. | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Olivia Newton-John Cancer Research Institute | 1 |
| University of California, Davis | 1 |
| Stanford University | 1 |
| Second Affiliated Hospital of Guangzhou Medical University | 1 |
| Guangzhou JOYO Pharma Co., Ltd | 1 |
| Radiomedix, Inc. | 1 |
| Children's National Research Institute | 1 |
| Columbia University | 1 |
| Suzhou Maximum Bio-tech Co., Ltd. | 1 |
| Hospital San Carlos, Madrid | 1 |
| Henry Ford Health System | 1 |
| University of Texas Southwestern Medical Center | 1 |
| UNC Lineberger Comprehensive Cancer Center | 1 |
| Seattle Children's Hospital | 1 |
| University of Utah | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 38 |
| China | 4 |
| Canada | 2 |
| France | 1 |
| Australia | 1 |
| Spain | 1 |
| Italy | 1 |
| United Kingdom | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Private investigators in the United States](https://specstream.ai/data/businesses/private-investigators/united-states)
- [Ultrasound imaging clinics in the United States](https://specstream.ai/data/businesses/ultrasound-imaging-clinics/united-states)
- [Behavior analysis services in the United States](https://specstream.ai/data/businesses/behavior-analysis-services/united-states)
- [Elevator companies in the United States](https://specstream.ai/data/businesses/elevator-companies/united-states)
- [IP and internet law firms in the United States](https://specstream.ai/data/businesses/ip-and-internet-law-firms/united-states)
- [Pipe suppliers in the United States](https://specstream.ai/data/businesses/pipe-suppliers/united-states)
